Adivir, Inc. entered into a definitive agreement to acquire Appili Therapeutics Inc. for $6.7 million on April 2, 2024. Under the terms of the Arrangement Agreement, shareholders of Appili will.
Adivir, Inc. entered into a definitive agreement to acquire Appili Therapeutics Inc. for $6.7 million on April 2, 2024. Under the terms of the Arrangement Agreement, shareholders of Appili will.
Transaction consideration provides a significant premium to the Appili shareholders Combined enterprise expected to provide enhanced synergies and resources to advance key programs NOT FOR DISTRIBUTION TO UNITED
Appili Therapeutics Biodefense Vaccine Candidate ATI-1701 is Awarded Additional Funding from the U S Air Force Academy streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Appili Therapeutics Announces Results of Annual Meeting of Shareholders and Provides Corporate Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.